Component
Purity of a commercial glucan preparation
Purity of a commercial glucan preparation. Species, exposure and limitations are retained in each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Laminarin is a (1->3, 1->6)-beta-glucan that is widely reported to be a Dectin-1 antagonist, however there are reports that laminarin is also a Dectin-1 agonist, and of five preparations from three commercial sources all contained laminarin although their molecular mass varied considerably from 4400 to 34,400 daltons, all were bound by recombinant human and mouse Dectin-1 but the affinity varied considerably and binding affinity did not correlate with Dectin-1 agonism, antagonism or potency, two laminarins were Dectin-1 antagonists and two were agonists, and the remaining laminarin was an antagonist but became an agonist when the low molecular weight moieties were removed.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/glucan-research/29246954.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5afc1ddc8e49971759dcdc432cedb4c22cad267cace1e3909dd577c8ebb9eaa6", "start_char": 0, "end_char": 1760, "text_sha256": "5afc1ddc8e49971759dcdc432cedb4c22cad267cace1e3909dd577c8ebb9eaa6"}
- experimental_model
- Physical, structural, purity, binding and functional comparison of five commercial laminarin preparations from three suppliers
- exposure
- Five laminarin preparations of molecular mass 4400 to 34,400 daltons, before and after extensive dialysis
- limitations
- Five preparations of one named natural product. Removing low molecular weight contaminants explained the behaviour of one preparation and not the others, so purity is one cause of the variation rather than the whole of it.
- nutrient_topic
- Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. · Beta-glucan
- organism
- Human and mouse cells
- plain_language
- Five bottles with the same name on the label: two blocked the receptor, two switched it on, and cleaning up a fifth flipped it.
- primary_references
- [bg-p29246954] Immunoregulatory Activity of the Natural Product Laminarin Varies Widely as a Result of Its Physical Properties. (2018). https://pubmed.ncbi.nlm.nih.gov/29246954/ DOI: 10.4049/jimmunol.1701258
- tissue_or_cell_type
- Recombinant receptor and primary cells
- trigger_kind
- biomarker_context Imported condition classification; unverified.
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Physical, structural, purity, binding and functional comparison of five commercial laminarin preparations from three suppliers · source_derived_draft · unverified_draft
### bg-same-name-opposite-activity Laminarin is a (1->3, 1->6)-beta-glucan that is widely reported to be a Dectin-1 antagonist, however there are reports that laminarin is also a Dectin-1 agonist, and of five preparations from three commercial sources all contained laminarin although their molecular mass varied considerably from 4400 to 34,400 daltons, all were bound by recombinant human and mouse Dectin-1 but the affinity varied considerably and binding affinity did not correlate with Dectin-1 agonism, antagonism or potency, two laminarins were Dectin-1 antagonists and two were agonists, and the remaining laminarin was an antagonist but became an agonist when the low molecular weight moieties were removed. Condition category: biomarker_context nutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. plain_language: Five bottles with the same name on the label: two blocked the receptor, two switched it on, and cleaning up a fifth flipped it. organism: Human and mouse cells tissue_or_cell_type: Recombinant receptor and primary cells experimental_model: Physical, structural, purity, binding and functional comparison of five commercial laminarin preparations from three suppliers limitations: Five preparations of one named natural product. Removing low molecular weight contaminants explained the behaviour of one preparation and not the others, so purity is one cause of the variation rather than the whole of it. exposure: Five laminarin preparations of molecular mass 4400 to 34,400 daltons, before and after extensive dialysis evidence_span: {"source_cache": "artifacts/glucan-research/29246954.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "5afc1ddc8e49971759dcdc432cedb4c22cad267cace1e3909dd577c8ebb9eaa6", "start_char": 0, "end_char": 1760, "text_sha256": "5afc1ddc8e49971759dcdc432cedb4c22cad267cace1e3909dd577c8ebb9eaa6"} [bg-p29246954] Immunoregulatory Activity of the Natural Product Laminarin Varies Widely as a Result of Its Physical Properties. (2018). https://pubmed.ncbi.nlm.nih.gov/29246954/ DOI: 10.4049/jimmunol.1701258
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.